DYRK1B and hepatocellular carcinoma: Supporting this notion, siRNA-mediated knockdown of DYRK1B in either BEL7402 or HepG2 cells decreased the effect of BafA1 on Cyclin D1 degradation and HCC cell growth (Fig. 2G,H).